Skip to main content

Together we are beating cancer

Donate now

Cancer News

Cancer Research UK-funded research

Showing 12 out of 974 results
Aneurin Bevan, founder of the NHS, visits a patient on the service's first day.

To celebrate 75 years of the NHS, we’ve put together a timeline showing some of its biggest contributions to cancer care.   To celebrate 75 years of the NHS, we’ve put together a timeline showing some of its biggest contributions to cancer care.  

by Tim Gunn | In depth | 5 July 2023

5 July 2023

A 3D illustration of red blood cells inside a vein or artery

New research has shown that a molecule called formaldehyde causes DNA damage to blood stem cells, which can accelerate their ageing and increase the likelihood of blood cancers. New research has shown that a molecule called formaldehyde causes DNA damage to blood stem cells, which can accelerate their ageing and increase the likelihood of blood cancers.

by Jacob Smith | Analysis | 29 June 2023

29 June 2023

Deborah James smiling at the camera while sitting on a sofa in a floral dress

We're remembering Dame Deborah James, a year on from her death. Here, our chief executive Michelle Mitchell pays a personal tribute. We're remembering Dame Deborah James, a year on from her death. Here, our chief executive Michelle Mitchell pays a personal tribute.

by Cancer Research UK | News | 28 June 2023

28 June 2023

Senedd Cymru, or the Welsh Parliament.

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change. Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

by Tim Gunn | News | 8 June 2023

8 June 2023

  • For Researchers

Harnessing the power of CD3

Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out... Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out...

by Phil Prime | Interview | 30 May 2023

30 May 2023

Andrea receiving chemotherapy.

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

by Tim Gunn | In depth | 22 May 2023

22 May 2023

Breast magnetic resonance image, or MRI. The bright white dot in the larger images is stage one breast cancer.

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

by Jacob Smith | Analysis | 9 May 2023

9 May 2023

Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health. Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health.

by Sophie Wedekind | Analysis | 27 April 2023

27 April 2023

Picture of the new Cancer Research UK Manchester Institute

Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place. Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place.

by Martin McGlown | Opinion | 26 April 2023

26 April 2023

Bowel cancer cells under the microscope

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

by Jacob Smith | In depth | 25 April 2023

25 April 2023